Publisher
Springer Berlin Heidelberg
Reference23 articles.
1. Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G, Kantarjian H, Raza A, Levine RL, Neuberg D, Ebert BL (2011) Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364:2496–2506
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) The French–American–British co-operative group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189–199
3. Brunning RD, Orazi A, Germing U, Le Beau MM, Porwit A, Baumann I (2008) Myelodysplastic syndromes. In: Swerdlow SH, Campo E, Lee Harris N, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 87–107
4. Cordoba I, Gonzalez Porras JR, Nomdedeu B, Luño E, De Paz R, Such E, Tormo M, Vallespi T, Collado R, Xicoy B, Andreu R, Muñoz JA, Solé F, Cervera J, Cañizo M (2012) Better prognosis for patients with del(7q) than those with monosomy 7 in myelodysyplastic syndromes. Cancer 118:127–133. doi: 10.1002/cncr.26279
5. Gondek LP, Tiu R, O’Keefe CL, Sekeres MA, Theil KS, Maciejewski JP (2008) Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 111:1534–1542